Generation of Induced Pluripotent Stem Cells (iPSCs) from a Hypertrophic Cardiomyopathy Patient with the Pathogenic Variant P.Val698Ala in Beta-myosin Heavy Chain (MYH7) Gene
Overview
Affiliations
Induced pluripotent stem cells (iPSCs) were generated from peripheral blood mononuclear cells (PBMCs) isolated from the whole blood of a 43-year-old male with hypertrophic cardiomyopathy (HCM) who carries the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7). Patient-derived PBMCs were reprogrammed using non-integrative episomal vectors containing reprogramming factors OCT4, SOX2, LIN28, KLF4 and L-MYC. iPSCs were shown to express pluripotent markers, have trilineage differentiation potential, carry the pathogenic MYH7 variant p.Val698Ala, have a normal karyotype and no longer carry the episomal reprogramming vector. This line is useful for studying the link between variants in MYH7 and the pathogenesis of HCM.
Ribeiro M, Jager J, Furtado M, Carvalho T, Cabral J, Brito D Hum Cell. 2024; 37(4):1205-1214.
PMID: 38762696 PMC: 11194200. DOI: 10.1007/s13577-024-01073-y.
Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target.
Dattani A, Singh A, McCann G, Gulsin G J Cardiovasc Dev Dis. 2024; 11(1).
PMID: 38248882 PMC: 10817027. DOI: 10.3390/jcdd11010012.
MYH7 in cardiomyopathy and skeletal muscle myopathy.
Gao Y, Peng L, Zhao C Mol Cell Biochem. 2023; 479(2):393-417.
PMID: 37079208 DOI: 10.1007/s11010-023-04735-x.
Li J, Feng X, Wei X Stem Cell Res Ther. 2022; 13(1):232.
PMID: 35659761 PMC: 9166443. DOI: 10.1186/s13287-022-02905-0.
Li Y, Lang S, Akin I, Zhou X, El-Battrawy I J Am Heart Assoc. 2022; 11(7):e024410.
PMID: 35322667 PMC: 9075459. DOI: 10.1161/JAHA.121.024410.